Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Getting the balance right: Established and emerging therapies for major depressive disorders

Authors Perović B, Jovanović M, Miljković B, Vezmar S

Published 5 July 2010 Volume 2010:6(1) Pages 343—364

DOI https://doi.org/10.2147/NDT.S10485

Review by Single-blind

Peer reviewer comments 3


Bojana Perovic, Marija Jovanovic, Branislava Miljkovic, Sandra Vezmar

Department of Pharmacokinetics, Faculty of Pharmacy, University of Belgrade, Serbia

Abstract: Major depressive disorder (MDD) is a common and serious illness of our times, associated with monoamine deficiency in the brain. Moreover, increased levels of cortisol, ­possibly caused by stress, may be related to depression. In the treatment of MDD, the use of older antidepressants such as monoamine oxidase inhibitors and tricyclic antidepressants is decreasing rapidly, mainly due to their adverse effect profiles. In contrast, the use of serotonin reuptake inhibitors and newer antidepressants, which have dual modes of action such as inhibition of the serotonin and noradrenaline or dopamine reuptake, is increasing. Novel antidepressants have additive modes of action such as agomelatine, a potent agonist of melatonin receptors. Drugs in development for treatment of MDD include triple reuptake inhibitors, dual-acting serotonin reuptake inhibitors and histamine antagonists, and many more. Newer antidepressants have similar efficacy and in general good tolerability profiles. Nevertheless, compliance with treatment for MDD is poor and may contribute to treatment failure. Despite the broad spectrum of available antidepressants, there are still at least 30% of depressive patients who do not benefit from treatment. Therefore, new approaches in drug development are necessary and, according to current research developments, the future of antidepressant treatment may be promising.

Keywords: major depressive disorders, monoamine deficiency, antidepressants, depression

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]